In the chemotherapy era, Sonpavde et al. demonstrated that serum albumin was externally validated as a prognostic factor for OS in addition to Hb, ECOG-PS, and liver metastasis in advanced UC patients with ten prospective phase II trials of salvage systemic agent therapy following platinum-based chemotherapy [31, 68]. This evidence concerns the gene ALB and metastasis.